NASDAQ:IRWD - Nasdaq - US46333X1081 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to IRWD. IRWD was compared to 561 industry peers in the Biotechnology industry. Both the profitability and the financial health of IRWD get a neutral evaluation. Nothing too spectacular is happening here. IRWD has a valuation in line with the averages, but on the other hand it scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 0.25% | ||
ROE | N/A | ||
ROIC | 24.23% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.24% | ||
PM (TTM) | 0.25% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 5.65 | ||
Altman-Z | -4.29 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.69 | ||
Quick Ratio | 4.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 2.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 0.89 | ||
EV/EBITDA | 6.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:IRWD (5/23/2025, 2:29:00 PM)
0.5699
-0.05 (-8.1%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 2.07 | ||
P/S | 0.26 | ||
P/FCF | 0.89 | ||
P/OCF | 0.89 | ||
P/B | N/A | ||
P/tB | N/A | ||
EV/EBITDA | 6.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 0.25% | ||
ROE | N/A | ||
ROCE | 30.67% | ||
ROIC | 24.23% | ||
ROICexc | 33.83% | ||
ROICexgc | 34.27% | ||
OM | 27.24% | ||
PM (TTM) | 0.25% | ||
GM | N/A | ||
FCFM | 29.43% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 5.65 | ||
Debt/EBITDA | 5.98 | ||
Cap/Depr | 7.06% | ||
Cap/Sales | 0.04% | ||
Interest Coverage | 2.94 | ||
Cash Conversion | 105.96% | ||
Profit Quality | 11750.8% | ||
Current Ratio | 4.69 | ||
Quick Ratio | 4.69 | ||
Altman-Z | -4.29 |